Kluczowe dokumenty

Wyświetl całą dokumentację

Przejdź do

46461

Metronidazole

Name: Metronidazole
Brand: SIAL

VETRANAL^®, analytical standard

Synonim(y):

2-Methyl-5-nitroimidazole-1-ethanol

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok

Gabaryty przesyłki	SKU	Dostępność	Cena netto

Informacje o tej pozycji

Wzór empiryczny (zapis Hilla):

C₆H₉N₃O₃

Numer CAS:

443-48-1

Masa cząsteczkowa:

171.15

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329757194

EC Number:

207-136-1

Beilstein/REAXYS Number:

611683

MDL number:

MFCD00009750

Informacje o cenach i dostępności nie są obecnie dostępne.

Pomoc techniczna

Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.

Pozwól nam pomóc

Właściwości

grade

analytical standard

Quality Level

200

product line

VETRANAL^®

shelf life

limited shelf life, expiry date on the label

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

mp

159-161 °C (lit.)

antibiotic activity spectrum

Gram-negative bacteria, parasites

application(s)

clinical testing

format

neat

mode of action

DNA synthesis | interferes

storage temp.

2-8°C

SMILES string

CC1=NC=C([N+]([O-])=O)N1CCO

InChI

1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3

InChI key

VAOCPAMSLUNLGC-UHFFFAOYSA-N

Opis

General description

Chemical structure: imidazole

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Other Notes

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Legal Information

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja	M3761	PHR1052	M1547
Supelco 46461 Metronidazole	Supelco M3761 Metronidazole	Supelco PHR1052 Metronidazole	Sigma-Aldrich M1547 Metronidazole
technique(s) HPLC: suitable, gas chromatography (GC): suitable	technique(s) HPLC: suitable, gas chromatography (GC): suitable	technique(s) HPLC: suitable, gas chromatography (GC): suitable	technique(s) -
application(s) clinical testing	application(s) forensics and toxicology pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) -
format neat	format neat	format neat	format -
Quality Level 200	Quality Level 100	Quality Level 300	Quality Level 200
grade analytical standard	grade analytical standard	grade certified reference material, pharmaceutical secondary standard	grade -
storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-30°C	storage temp. 2-8°C

Still not finding the right product?

Explore all of our products under

pictograms

GHS08

signalword

Danger

hcodes

H340,H350,H373

pcodes

P202 - P260 - P280 - P308 + P313 - P405 - P501

Hazard Classifications

Carc. 1B - Muta. 1B - STOT RE 2

Klasa składowania

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Wyszukaj dokument COA

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Christina M Surawicz et al.

The American journal of gastroenterology, 108(4), 478-498 (2013-02-27)

Clostridium difficile infection (CDI) is a leading cause of hospital-associated gastrointestinal illness and places a high burden on our health-care system. Patients with CDI typically have extended lengths-of-stay in hospitals, and CDI is a frequent cause of large hospital outbreaks

Antibiotic prophylaxis for hysterectomy, a prospective cohort study: cefuroxime, metronidazole, or both?

T H I Brummer et al.

BJOG : an international journal of obstetrics and gynaecology, 120(10), 1269-1276 (2013-06-22)

To evaluate cefuroxime and metronidazole antibiotic prophylaxis. Observational nonrandomised 1-year prospective cohort study. Fifty-three hospitals in Finland. A total of 5279 women undergoing hysterectomy for benign indications, with cefuroxime given to 4301 and metronidazole given to 2855. Excluding other antibiotics

Metronidazole is still the drug of choice for treatment of anaerobic infections.

Sonja Löfmark et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 50 Suppl 1, S16-S23 (2010-01-14)

Metronidazole has been used for the treatment of infections for >45 years and is still successfully used for the treatment of trichomoniasis, amoebiasis, and giardiasis. Anaerobic bacterial infections caused by Bacteroides species, fusobacteria, and clostridia respond favorably to metronidazole therapy.

Wyświetl wszystkie powiązane dokumenty

Numer pozycji handlu globalnego

SKU	NUMER GTIN
46461-250MG	04061832356594

Questions

Reviews

No rating value